Related Experiment Videos
Antimicrobial prophylaxis with ceftriaxone in neurosurgical procedures. A prospective study of 100 patients
1Department of Neurosurgery, Lecco Hospital, Italy.
Abstract:
Shunt infection is a major complication of shunt implantation, with Staphylococcus epidermidis found in almost 45% of infected shunts. This pathogen produces an extracellular slime that enables it to adhere to implantable devices and resist antibiotic therapy. Antimicrobial prophylaxis can prevent slime production. In this paper we report the results of a prospective study involving 100 shunt operations. The objective was to evaluate the efficacy of a single preoperative dose of ceftriaxone (2 g, i.v.) in preventing shunt infection. Ceftriaxone was chosen for its pharmacokinetic properties. No shunt infection was observed over a 4-year follow-up period. On the basis of these results we recommend prophylaxis with ceftriaxone as a safe and effective way of preventing shunt infection. In addition, one-shot prophylaxis with ceftriaxone is more cost-effective than multiple-dose antibiotic regimens.
Insights
A single preoperative dose of ceftriaxone effectively prevented shunt infections in 100 patients over four years. This one-shot antibiotic prophylaxis is a safe, cost-effective strategy against Staphylococcus epidermidis shunt infections.
Area of Science:
- Neurosurgery
- Infectious Diseases
- Pharmacology
Background:
- Shunt infection is a significant complication following shunt implantation surgery.
- Staphylococcus epidermidis causes nearly 45% of shunt infections, forming slime that promotes device adherence and antibiotic resistance.
- Antimicrobial prophylaxis is crucial for preventing slime production and subsequent infections.
Purpose of the Study:
- To evaluate the efficacy of a single preoperative intravenous dose of ceftriaxone (2 g) in preventing shunt infections.
- To assess the safety and cost-effectiveness of this prophylactic regimen.
Main Methods:
- A prospective study was conducted involving 100 patients undergoing shunt operations.
- Patients received a single preoperative dose of ceftriaxone (2 g, i.v.).
- Follow-up was conducted over a 4-year period to monitor for shunt infections.
Main Results:
- No shunt infections were observed in any of the 100 patients during the 4-year follow-up period.
- Ceftriaxone demonstrated favorable pharmacokinetic properties for this prophylactic use.
- The single-dose regimen proved to be more cost-effective than multiple-dose antibiotic treatments.
Conclusions:
- A single preoperative dose of ceftriaxone is a safe and effective method for preventing shunt infections.
- This one-shot prophylaxis strategy offers a cost-effective alternative to traditional multi-dose regimens.
- Ceftriaxone prophylaxis is recommended for reducing the incidence of shunt infections, particularly those caused by Staphylococcus epidermidis.